BVB RON

Biofarm S.A. (BIO.RO)

Compare
0.7400 -0.0020 (-0.27%)
As of 2:16:47 PM GMT+2. Market Open.
Loading Chart for BIO.RO
DELL
  • Previous Close 0.7420
  • Open 0.7420
  • Bid 0.7280 x --
  • Ask 0.7400 x --
  • Day's Range 0.7260 - 0.7420
  • 52 Week Range 0.6600 - 0.9100
  • Volume 8,669
  • Avg. Volume 29,637
  • Market Cap (intraday) 729.172M
  • Beta (5Y Monthly) 0.32
  • PE Ratio (TTM) 10.57
  • EPS (TTM) 0.0700
  • Earnings Date --
  • Forward Dividend & Yield 0.03 (4.13%)
  • Ex-Dividend Date Aug 20, 2024
  • 1y Target Est --

Biofarm S.A. engages in the manufacture and sale of medicines in Romania. The company offers a portfolio of products covering therapeutic areas, such as antiallergics, cardiovascular and circulatory, analgesics and antipyretics, dermatology, digestive and metabolic, endocrine, genitourinary, multivitamins, ophthalmology, musculoskeletal, respiratory and ENT, and neurology. It provides prescription and non-prescription medicines, food supplements, medical devices, cosmetics, and other products. The company also exports its products in Azerbaijan, Albania, Georgia, Iraq, Kyrgyzstan, Hungary, and Republic of Moldova. Biofarm S.A. was incorporated in 1921 and is headquartered in Bucharest, Romania.

www.biofarm.ro

378

Full Time Employees

December 31

Fiscal Year Ends

Recent News: BIO.RO

View More

Performance Overview: BIO.RO

Trailing total returns as of 12/12/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BIO.RO
6.60%
MSCI WORLD
21.30%

1-Year Return

BIO.RO
6.83%
MSCI WORLD
25.78%

3-Year Return

BIO.RO
3.06%
MSCI WORLD
20.58%

5-Year Return

BIO.RO
171.88%
MSCI WORLD
67.51%

Compare To: BIO.RO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BIO.RO

View More

Valuation Measures

Annual
As of 12/11/2024
  • Market Cap

    731.14M

  • Enterprise Value

    599.97M

  • Trailing P/E

    9.95

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.59

  • Price/Book (mrq)

    1.53

  • Enterprise Value/Revenue

    2.12

  • Enterprise Value/EBITDA

    5.67

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.57%

  • Return on Assets (ttm)

    8.29%

  • Return on Equity (ttm)

    16.28%

  • Revenue (ttm)

    259.28M

  • Net Income Avi to Common (ttm)

    68.89M

  • Diluted EPS (ttm)

    0.0700

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    132.08M

  • Total Debt/Equity (mrq)

    0.20%

  • Levered Free Cash Flow (ttm)

    20.99M

Research Analysis: BIO.RO

View More

Company Insights: BIO.RO

Research Reports: BIO.RO

View More

People Also Watch